말초신경병증 치료 시장(2026-2030년)

The global peripheral neuropathy treatment market is forecasted to grow by USD 504107.4 thousand during 2025-2030, accelerating at a CAGR of 4.5% during the forecast period. The report on the global peripheral neuropathy treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of peripheral neuropathy, recent drug approvals for peripheral neuropathy, rising awareness of peripheral neuropathy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global peripheral neuropathy treatment market is segmented as below:

By Type

• Diabetic
• Chemotherapy
• Others

By Therapy

• Pharmacological therapies
• Non pharmacological therapies

By Diagnostic Methods

• Blood test
• Biopsy
• Imaging

By End-User

• Hospitals and clinics
• Retail pharmacy
• Online pharmacy

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the strong drug pipeline is augmenting market growth as one of the prime reasons driving the global peripheral neuropathy treatment market growth during the next few years. Also, technological advances with new formulations of drugs and increase in research and development associated with peripheral neuropathy treatment will lead to sizable demand in the market.

The report on the global peripheral neuropathy treatment market covers the following areas:

• Global peripheral neuropathy treatment market sizing
• Global peripheral neuropathy treatment market forecast
• Global peripheral neuropathy treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global peripheral neuropathy treatment market vendors that include Abbott Laboratories, Aurobindo Pharma Ltd., Boston Scientific Corp., Cipla Inc., Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Grunenthal GmbH, Hisamitsu Pharmaceutical Co, Lupin Ltd., Medtronic Plc, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., UCB SA, Viatris Inc., Woerwag Pharma GmbH and Co, Zydus Lifesciences Ltd.. Also, the global peripheral neuropathy treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Therapy
  • Executive Summary - Chart on Market Segmentation by Diagnostic Methods
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Peripheral Neuropathy Treatment Market 2020 - 2024
  • Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2020 - 2024 ($ thousand)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
• 5.3 Therapy segment analysis 2020 - 2024
  • Historic Market Size - Therapy Segment 2020 - 2024 ($ thousand)
• 5.4 Diagnostic Methods segment analysis 2020 - 2024
  • Historic Market Size - Diagnostic Methods Segment 2020 - 2024 ($ thousand)
• 5.5 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Peripheral Neuropathy Treatment Market
• 6.2 Impact of Geopolitical Conflicts on Global Peripheral Neuropathy Treatment Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Diabetic - Market size and forecast 2025-2030
• 8.4 Chemotherapy - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ thousand)

9 Market Segmentation by Therapy

• 9.1 Market segments
• 9.2 Comparison by Therapy
• 9.3 Pharmacological therapies - Market size and forecast 2025-2030
• 9.4 Non pharmacological therapies - Market size and forecast 2025-2030
• 9.5 Market opportunity by Therapy
  • Market opportunity by Therapy ($ thousand)

10 Market Segmentation by Diagnostic Methods

• 10.1 Market segments
• 10.2 Comparison by Diagnostic Methods
• 10.3 Blood test - Market size and forecast 2025-2030
• 10.4 Biopsy - Market size and forecast 2025-2030
• 10.5 Imaging - Market size and forecast 2025-2030
• 10.6 Market opportunity by Diagnostic Methods
  • Market opportunity by Diagnostic Methods ($ thousand)

11 Market Segmentation by End-user

• 11.1 Market segments
• 11.2 Comparison by End-user
• 11.3 Hospitals and clinics - Market size and forecast 2025-2030
• 11.4 Retail pharmacy - Market size and forecast 2025-2030
• 11.5 Online pharmacy - Market size and forecast 2025-2030
• 11.6 Market opportunity by End-user
  • Market opportunity by End-user ($ thousand)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 North America - Market size and forecast 2025-2030
  • 13.3.1 US - Market size and forecast 2025-2030
  • 13.3.2 Canada - Market size and forecast 2025-2030
  • 13.3.3 Mexico - Market size and forecast 2025-2030
• 13.4 Europe - Market size and forecast 2025-2030
  • 13.4.1 Germany - Market size and forecast 2025-2030
  • 13.4.2 UK - Market size and forecast 2025-2030
  • 13.4.3 France - Market size and forecast 2025-2030
  • 13.4.4 Italy - Market size and forecast 2025-2030
  • 13.4.5 Spain - Market size and forecast 2025-2030
  • 13.4.6 The Netherlands - Market size and forecast 2025-2030
• 13.5 Asia - Market size and forecast 2025-2030
  • 13.5.1 China - Market size and forecast 2025-2030
  • 13.5.2 India - Market size and forecast 2025-2030
  • 13.5.3 Japan - Market size and forecast 2025-2030
  • 13.5.4 South Korea - Market size and forecast 2025-2030
  • 13.5.5 Indonesia - Market size and forecast 2025-2030
  • 13.5.6 Thailand - Market size and forecast 2025-2030
• 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 13.6.1 Brazil - Market size and forecast 2025-2030
  • 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.3 UAE - Market size and forecast 2025-2030
  • 13.6.4 Turkey - Market size and forecast 2025-2030
  • 13.6.5 Argentina - Market size and forecast 2025-2030
  • 13.6.6 Colombia - Market size and forecast 2025-2030
  • 13.6.7 South Africa - Market size and forecast 2025-2030
  • 13.6.8 Israel - Market size and forecast 2025-2030
• 13.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Increasing prevalence of peripheral neuropathy
  • Recent drug approvals for peripheral neuropathy
  • Rising awareness of peripheral neuropathy
• 14.2 Market challenges
  • Side effects of medications used for peripheral neuropathy
  • Complications involved in diagnosis of peripheral neuropathy
  • Stringent regulations and product discontinuation
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Strong drug pipeline is augmenting market growth
  • Technological advances with new formulations of drugs
  • Increase in research and development associated with peripheral neuropathy treatment

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 16.5 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key news
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 16.6 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
• 16.7 Daiichi Sankyo Co. Ltd.
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Business segments
  • Daiichi Sankyo Co. Ltd. - Key news
  • Daiichi Sankyo Co. Ltd. - Key offerings
  • Daiichi Sankyo Co. Ltd. - Segment focus
  • SWOT
• 16.8 Dr. Reddys Laboratories Ltd.
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key news
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • SWOT
• 16.9 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
• 16.10 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key news
  • Glenmark Pharmaceuticals Ltd. - Key offerings
  • SWOT
• 16.11 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
• 16.12 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 16.13 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Segment focus
  • SWOT
• 16.14 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 16.15 Sun Pharmaceutical Industries
  • Sun Pharmaceutical Industries - Overview
  • Sun Pharmaceutical Industries - Business segments
  • Sun Pharmaceutical Industries - Key news
  • Sun Pharmaceutical Industries - Key offerings
  • Sun Pharmaceutical Industries - Segment focus
  • SWOT
• 16.16 Teva Pharmaceutical Ltd.
  • Teva Pharmaceutical Ltd. - Overview
  • Teva Pharmaceutical Ltd. - Business segments
  • Teva Pharmaceutical Ltd. - Key news
  • Teva Pharmaceutical Ltd. - Key offerings
  • Teva Pharmaceutical Ltd. - Segment focus
  • SWOT
• 16.17 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
  • SWOT
• 16.18 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations